Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rethinking the role of hydroxychloroquine in the treatment of COVID‐19
Eric A. Meyerowitz, Augustin Vannier, Morgan G. N. Friesen, et al.
The FASEB Journal (2020) Vol. 34, Iss. 5, pp. 6027-6037
Open Access | Times Cited: 177

Showing 26-50 of 177 citing articles:

A Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients.
Abu Taiub Mohammed Mohiuddin Chowdhury, Mohammad Shahbaz, Md Rezaul Karim, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 46
Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity
Е. Л. Насонов, Т. V. Beketova, Т. М. Reshetnyak, et al.
Rheumatology Science and Practice (2020) Vol. 58, Iss. 4, pp. 353-367
Open Access | Times Cited: 40
Streptomyces griseiviridis sp. nov., A Novel “Modern Actinobacteria” isolated from Malaysia Mangrove Soil
Jodi Woan‐Fei Law, Loh Teng‐Hern Tan, Vengadesh Letchumanan, et al.
Progress In Microbes & Molecular Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 12
Update and Recommendations for Ocular Manifestations of COVID-19 in Adults and Children: A Narrative Review
Veena Danthuluri, Maria B. Grant
Ophthalmology and Therapy (2020) Vol. 9, Iss. 4, pp. 853-875
Open Access | Times Cited: 36
Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19
Christina B. Klouda, William L. Stone
Antioxidants (2020) Vol. 9, Iss. 9, pp. 894-894
Open Access | Times Cited: 34
Review on therapeutic targets for COVID-19: insights from cytokine storm
Mário Luciano de Mélo Silva Júnior, Lívia Maria Alves de Souza, Renata Ellen Maria Carvalho Dutra, et al.
Postgraduate Medical Journal (2020) Vol. 97, Iss. 1148, pp. 391-398
Open Access | Times Cited: 34
Covid-19 in kidney transplant recipients: a systematic review of the case series available three months into the pandemic
Mihai Oltean, John Mackay Søfteland, Jasmine Bagge, et al.
Infectious Diseases (2020) Vol. 52, Iss. 11, pp. 830-837
Open Access | Times Cited: 33
Safety profile of COVID-19 drugs in a real clinical setting
Mei Nee Chiu, Maitry Bhardwaj, Sangeeta Pilkhwal Sah
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 5, pp. 733-753
Open Access | Times Cited: 21
Efficacy and safety of interferon beta-1a in treatment of severe COVID-19: A randomized clinical trial
Effat Davoudi-Monfared, Hamid Rahmani, Hossein Khalili, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 30
A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation
Anand Singh, Sultan Tousif, Prachi Umbarkar, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 1867-1867
Open Access | Times Cited: 29
An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia
Purwati Purwati, Andang Miatmoko, Nasronudin Nasronudin, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0252302-e0252302
Open Access | Times Cited: 23
The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19
Zelyn Lee, Craig R. Rayner, Jamie I. Forrest, et al.
American Journal of Tropical Medicine and Hygiene (2020) Vol. 104, Iss. 1, pp. 35-38
Open Access | Times Cited: 26
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
Desh Deepak Singh, Ihn Han, Eun Ha Choi, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 25
No Small Matter: A Perspective on Nanotechnology-Enabled Solutions to Fight COVID-19
Georgia Wilson Jones, Marco P. Monopoli, Luisa Campagnolo, et al.
Nanomedicine (2020) Vol. 15, Iss. 24, pp. 2411-2427
Open Access | Times Cited: 24
COVID-19 Pandemic: Time to Revive the Cyclophilin Inhibitor Alisporivir
Jean‐Michel Pawlotsky
Clinical Infectious Diseases (2020) Vol. 71, Iss. 16, pp. 2191-2194
Open Access | Times Cited: 23
Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns
Hazem Mslati, Francesco Gentile, Carl F. Perez, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 8, pp. 3771-3788
Closed Access | Times Cited: 22
Molecular recognition in the infection, replication, and transmission of COVID-19-causing SARS-CoV-2: an emerging interface of infectious disease, biological chemistry, and nanoscience
Prem Kumar, Jeladhara Sobhanan, Yuta Takano, et al.
NPG Asia Materials (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Hydroxychloroquine interaction with phosphoinositide 3-kinase modulates prostate cancer growth in bone microenvironment: In vitro and molecular dynamics based approach
K.M. Abdullah, Gunjan Sharma, Faizan Abul Qais, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 130912-130912
Closed Access | Times Cited: 2
Prophylactic (hydroxy)chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk
Joost A. Offerhaus, Arthur A.M. Wilde, Carol Ann Remme
Heart Rhythm (2020) Vol. 17, Iss. 9, pp. 1480-1486
Open Access | Times Cited: 23
Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2
Hamed Gilzad Kohan, Fakhreddin Jamali
Journal of Pharmacy & Pharmaceutical Sciences (2020) Vol. 23, pp. 259-277
Open Access | Times Cited: 23
Assessment of COVID‐19 Treatment containing both Hydroxychloroquine and Azithromycin: A natural clinical trial
Hassan Abbas, Ali Azeez Al‐Jumaili, Kawthar Faris Nassir, et al.
International Journal of Clinical Practice (2020) Vol. 75, Iss. 4
Open Access | Times Cited: 21
Development of a chiral HPLC method for the separation and quantification of hydroxychloroquine enantiomers
Xisheng Xiong, Kun Wang, Tao Tang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy
Xin Peng, Shaolu Zhang, Wenhui Jiao, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 19
Perturbed Lipid Metabolism Transduction Pathways in SARS-CoV-2 Infection and Their Possible Treating Nutraceuticals
Amrita Shukla, Ankita Singh, Smriti Tripathi
Journal of the American Nutrition Association (2024) Vol. 43, Iss. 7, pp. 614-626
Closed Access | Times Cited: 2
Closing the Gap on COVID-19 Vaccinations in First Responders and Beyond: Increasing Trust
Megan E. Gregory, Sarah R. MacEwan, Alice A. Gaughan, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 2, pp. 644-644
Open Access | Times Cited: 11

Scroll to top